Literature DB >> 2360826

Serum sickness-like illness associated with ciprofloxacin.

T G Slama1.   

Abstract

Serum sickness is a systemic hypersensitivity reaction initially reported in children receiving horse serum. Drugs such as penicillins, cephalosporins, and sulfonamides are now noted to be the most common etiologic agents of serum sickness-like reactions. This case report describes a serum sickness-like reaction temporally related to ciprofloxacin, a previously unreported adverse effect of this drug or any of the other quinolones.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2360826      PMCID: PMC171716          DOI: 10.1128/AAC.34.5.904

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Anaphylactoid reactions reported after treatment with ciprofloxacin.

Authors:  H Davis; E McGoodwin; T G Reed
Journal:  Ann Intern Med       Date:  1989-12-15       Impact factor: 25.391

2.  Serum sickness-like reactions to amoxicillin, cefaclor, cephalexin, and trimethoprim-sulfamethoxazole.

Authors:  R Platt; M W Dreis; D L Kennedy; J N Kuritsky
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

Review 3.  The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

4.  Ciprofloxacin-induced vasculitis.

Authors:  U Choe; B M Rothschild; L Laitman
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

5.  Serum sickness syndrome.

Authors:  R Y Lin
Journal:  Am Fam Physician       Date:  1986-01       Impact factor: 3.292

Review 6.  Adverse reactions associated with the use of oral penicillins and cephalosporins.

Authors:  A Alanis; A J Weinstein
Journal:  Med Clin North Am       Date:  1983-01       Impact factor: 5.456

Review 7.  Acute renal failure secondary to oral ciprofloxacin therapy: a presentation of three cases and a review of the literature.

Authors:  R Hootkins; A Z Fenves; M K Stephens
Journal:  Clin Nephrol       Date:  1989-08       Impact factor: 0.975

8.  A prospective clinical and immunologic analysis of patients with serum sickness.

Authors:  T J Lawley; L Bielory; P Gascon; K B Yancey; N S Young; M M Frank
Journal:  N Engl J Med       Date:  1984-11-29       Impact factor: 91.245

  8 in total
  7 in total

Review 1.  Tolerability of fluoroquinolone antibiotics. Past, present and future.

Authors:  P Ball; G Tillotson
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Paediatric serum sickness-like reaction: A 10-year retrospective cohort study.

Authors:  Blanca R Del Pozzo-Magaña; Awatif Abuzgaia; Barbara Murray; Michael J Rieder; Alejandro Lazo-Langner
Journal:  Paediatr Child Health       Date:  2021-04-03       Impact factor: 2.253

3.  Post-marketing surveillance of quinolones 1988-1990.

Authors:  P G Davey; T McDonald; G Lindsay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 4.  Do we need an intravenous fluoroquinolone?

Authors:  D S Maddix; L Warner
Journal:  West J Med       Date:  1992-07

Review 5.  Cutaneous drug reactions in children: an update.

Authors:  Kara Heelan; Neil H Shear
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

6.  Serum sickness-like reaction associated with cefazolin.

Authors:  Michael Brucculeri; Marian Charlton; David Serur
Journal:  BMC Clin Pharmacol       Date:  2006-02-23

7.  Mild cutaneous reactions to drugs.

Authors:  Giuseppe Crisafulli; Fabrizio Franceschini; Silvia Caimmi; Paolo Bottau; Lucia Liotti; Francesca Saretta; Roberto Bernardini; Fabio Cardinale; Francesca Mori; Carlo Caffarelli
Journal:  Acta Biomed       Date:  2019-01-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.